Immix Biopharma Inc logo

Manager, Financial Reporting and Accounting

Salary
$115K–$165K
USD per year
Hiring from
United States
Work type
Remote
Posted
Oct 2, 2026
Is this job info correct?

Manager of Financial Reporting & Accounting, responsible for reviewing monthly and quarterly close document, SEC filings, equity administration, regulatory financial reporting, and external audit relationship. Reporting directly to the VP of Finance & Accounting. Reviews and prepares financial documents as assigned. The role is perfect for a Big 4 senior or manager who wants real ownership, direct exposure to the CFO-level agenda, the Audit Committee cycle, and a company moving from clinical-stage toward commercialization.

Key responsibilities

Monthly and quarterly close

• Lead review of the monthly and quarterly close: journal entries, account reconciliations, accruals and flux analysis, working with our outsourced and internal preparers.

• Own the close calendar and checklist; drive it to a timeline that supports 10-Q and 10-K deadlines.

• Review R&D accounting, including clinical trial accruals and prepaid balances for CROs, CDMOs and investigator sites, with input from clinical operations.

• Prepare or review technical accounting memos for new agreements and non-routine transactions (financings, warrants, license and collaboration agreements, leases).

SEC reporting

• Prepare and review Forms 10-Q and 10-K, including financial statements, footnotes, MD&A and XBRL tagging review.

• Support Forms 8-K, proxy statement compensation and equity tables, Section 16 support, and registration statements (S-3, S-8, ATM and offering-related filings, comfort letter support).

• Maintain the disclosure checklist, tie-out binders and support packages; coordinate with outside counsel, the financial printer and the Disclosure Committee.

• Monitor new SEC rules and FASB standards and assess their impact on the company.

Equity administration oversight and reporting

• Oversee the equity plan administrator and the equity ledger: grants, exercises, cancellations, share reserve and plan limits.

• Own stock-based compensation accounting under ASC 718: valuation inputs, expense schedules, modifications, and footnote disclosure.

• Prepare EPS and dilution calculations, warrant and option roll-forwards, and equity reporting for the Board and Compensation Committee.

Regulatory financial reporting

• Prepare or coordinate non-SEC financial filings: Nasdaq compliance items, government surveys, state and local filings, and foreign subsidiary statutory reporting as applicable.

• Coordinate with external tax advisors on the income tax provision (ASC 740), R&D credits and related filings.

• Support financial data required for grant, federal healthcare or transparency reporting as the company approaches commercialization.

External audit and internal controls

• Serve as the day-to-day contact for the external auditors on quarterly reviews and the annual audit: PBC lists, timelines, open-item tracking and issue resolution.

• Maintain and improve SOX internal controls over financial reporting: risk assessment, control documentation, key report and IPE support, and remediation of any findings.

• Help prepare Audit Committee materials each quarter.

Building for what is next

• Help design the accounting policies, processes and controls needed for commercial launch: inventory and cost of goods, revenue recognition (ASC 606), gross-to-net, and system improvements.

• Identify and implement process automation in a small-team environment.


Qualifications

Required

• Bachelor's degree in accounting or a related field; active CPA (or all exam sections passed).

• 5 to 8+ years of progressive experience, including Big 4 audit experience at the senior or manager level serving SEC registrants.

• Hands-on experience preparing or auditing Forms 10-Q and 10-K, with strong working knowledge of U.S. GAAP, SEC reporting rules (Regulation S-X and S-K) and SOX 404.

• Working knowledge of stock-based compensation (ASC 718), equity and warrant accounting, and EPS.

• Proven ability to work independently on a small team: you review at a manager level and are equally willing to build the schedule yourself.

• Clear writing. You can draft a footnote, an accounting memo and an Audit Committee slide without heavy editing.

• Strong Excel skills and comfort with a cloud ERP, an equity administration platform and SEC filing/XBRL software.

Preferred

• Experience with public life sciences companies, ideally covering both R&D-stage and commercial-stage pharma or biotech, as an auditor or in industry.

• Familiarity with clinical trial accruals, CRO and CDMO contracts, and license or collaboration agreements.

• Exposure to commercial-launch accounting: inventory, ASC 606 revenue and gross-to-net.

• Experience with capital markets transactions (ATM programs, follow-on offerings, shelf registrations, comfort letters).

• Experience at a smaller reporting company or emerging growth company where one person covers a lot of ground.

• One to three years in industry after public accounting is a plus, not a requirement.


Why this role

• Ownership. You are the second senior finance professional at a Nasdaq-listed company, not one reviewer among many. Your work goes to the CFO-level agenda, the Audit Committee and the SEC.

• Breadth. Close, SEC reporting, equity, audit and controls in one seat. Few roles at larger companies offer that range before the Director level.

• Support. You work directly with the VP of Finance & Accounting, who stays close to the technical work and is invested in your development.

• Timing. You join ahead of a potential commercial transition and help build the finance function that supports it.

• Path. Clear room to grow into Senior Manager, Director of SEC Reporting or Controller as the company scales.


In your first 12 months you will have led review of four quarter-end closes, filed three 10-Qs and a 10-K on time, run a clean annual audit and SOX cycle as the auditors' day-to-day contact, and taken over equity administration oversight and stock compensation reporting.


Equal Opportunity Statement

Immix Biopharma is an equal opportunity employer. The company is committed to building a diverse and inclusive workplace and considers qualified applicants without regard to race, color, religion, sex, national origin, disability, veteran status, age, or any other status protected by applicable law.

Similar jobs

Apply for this job